November 18, 2026
Health news, explained with evidence
LIVE

SEER Database Study Reveals Long-Term Cancer Trends and Pandemic Disruptions

🧠 Mind & Mental Health 2 min read 👁 3

A new population-based study in Nature Health Sciences evaluates long-term incidence trends of screen-detectable cancers from 2000 to 2022, highlighting significant declines prior to the COVID-19 pandemic.

🧠Mind & Mental Health

Key points

  • Analyzed SEER registry data from 2000 to 2022 for adults aged 40 and older.
  • Identified significant long-term incidence declines in lung, colorectal, and cervical cancers.
  • Observed notable deviations and reductions in cancer diagnosis rates during the 2020 pandemic period.

A recent study published in Nature Health Sciences examined long-term incidence trends and pandemic-era changes for cancers with established screening guidelines in the United States. Researchers analyzed data from the Surveillance, Epidemiology, and End Results (SEER) 21 registries database, focusing on adults aged 40 and older between 2000 and 2022. The investigation covered lung and bronchus, colon and rectum, breast, and cervical cancers.

According to the findings, long-term incidence rates declined significantly over the two-decade span for lung and bronchus cancers (with an average annual percentage change of -1.81%), colorectal cancers (-1.94%), and cervical cancers (-1.48%). Meanwhile, breast cancer incidence showed no statistically significant overall change (-0.32%). During the COVID-19 pandemic years of 2020 to 2022, observed incidence rates for several cancer categories deviated from expectations based on pre-pandemic trajectories, showing the largest reductions in 2020 followed by variable recovery patterns.

The authors noted that population-level analyses rely on observational registry data, which inherently present limitations such as potential variations in healthcare access, utilization, and diagnostic coding over time. Stage distributions among diagnosed cases demonstrated only modest year-to-year fluctuations across the evaluated sites. The researchers emphasize that maintaining resilient preventive and diagnostic services during public health emergencies remains vital to prevent delays in timely cancer detection.

What to know: Long-term data through 2022 shows steady declines in US lung, colorectal, and cervical cancer incidence among adults over 40, alongside notable pandemic-related dips in 2020. Always consult a qualified healthcare provider for personalized medical decisions, cancer screening schedules, and health concerns.

Source Nature Health Sciences — nature.com/articles/s41598-026-77995-4 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.